Skip to content

Tribute Pharmaceuticals Canada Inc.: 10-K filed 2015-03-03

What Tribute Pharmaceuticals Canada Inc. reported in its annual report filed 2015-03-03 (fiscal FY 2014): 38 published measures, 76 facts as tagged in accession 0001354488-15-000926.

This filing

Form
10-K (annual report)
Filed
2015-03-03
Fiscal period
fiscal FY 2014
Accession
0001354488-15-000926 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Tribute Pharmaceuticals Canada Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-12-3153,079,740CAD
At 2013-12-3120,034,541CAD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-12-3122,739,009CAD
At 2013-12-3112,134,428CAD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-12-3130,340,731CAD
At 2013-12-317,900,113CAD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-12-313,505,791CAD
At 2013-12-312,813,472CAD
At 2012-12-312,283,868CAD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-5,606,942CAD365
2013-01-01 to 2013-12-31-6,572,355CAD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-1,888,085CAD365
2013-01-01 to 2013-12-31-5,197,043CAD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-12-3112,759CAD365
2013-01-01 to 2013-12-3126,795CAD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-01-01 to 2014-12-3116,871,792CAD365
2013-01-01 to 2013-12-3113,440,361CAD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-12-3135,946,434CAD365
2013-01-01 to 2013-12-315,860,981CAD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-32,586,574CAD365
2013-01-01 to 2013-12-31-60,140CAD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-12-31-19,902,853CAD
At 2013-12-31-14,295,911CAD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-01-01 to 2014-12-3171,940,005shares365
2013-01-01 to 2013-12-3149,169,414shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-01-01 to 2014-12-3171,940,005shares365
2013-01-01 to 2013-12-3149,169,414shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-0.08CAD/shares365
2013-01-01 to 2013-12-31-0.13CAD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-0.08CAD/shares365
2013-01-01 to 2013-12-31-0.13CAD/shares365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-12-311,012,285CAD
At 2013-12-311,089,919CAD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-12-31426,715CAD365
2013-01-01 to 2013-12-31419,167CAD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-12-317,150,347CAD
At 2013-12-315,374,660CAD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-01-01 to 2014-12-311,441,729CAD365
2013-01-01 to 2013-12-31527,079CAD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-12-318,771,516CAD
At 2013-12-316,494,326CAD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2014-12-313,599,077CAD
At 2013-12-313,599,077CAD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2014-12-3140,540,150CAD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-12-312,145,319CAD
At 2013-12-31591,766CAD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-01-01 to 2014-12-3111,660,875CAD365
2013-01-01 to 2013-12-3110,735,425CAD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-12-311,037,387CAD
At 2013-12-311,044,831CAD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-01-01 to 2014-12-319,129,075CAD365
2013-01-01 to 2013-12-315,997,270CAD365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2014-01-01 to 2014-12-3110,149,854CAD365
2013-01-01 to 2013-12-319,489,579CAD365

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-12-312,713,605CAD
At 2013-12-312,286,890CAD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2014-12-31290,700CAD
At 2013-12-310CAD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-12-312,154,674CAD
At 2013-12-312,141,915CAD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-12-311,142,389CAD
At 2013-12-311,051,996CAD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-12-3140,958,870CAD
At 2013-12-319,717,173CAD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-12-31187,279CAD
At 2013-12-31165,886CAD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-5,606,942CAD365
2013-01-01 to 2013-12-31-6,610,511CAD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-5,606,942CAD365
2013-01-01 to 2013-12-31-6,572,355CAD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-01-01 to 2014-12-311,332,118CAD365
2013-01-01 to 2013-12-311,038,152CAD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-1,553,553CAD365
2013-01-01 to 2013-12-31613,321CAD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-317,444CAD365
2013-01-01 to 2013-12-31-44,274CAD365

Inspect the source

Entity
Tribute Pharmaceuticals Canada Inc. / CIK 0001159019
Captured
SEC response SHA-256
580713a84aa79c7c06f7641b783696cf8e0676bb71dd55f93cd67e6d441393a2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001159019.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))